XOMA Corporation Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Financial Statements Detail (Tables)

Condensed Consolidated Financial Statements Detail (Tables)

6 Months Ended

Jun. 30, 2020

Condensed Consolidated Financial Statements Detail [Abstract]

Accrued and other liabilities consisted of the following (in thousands):


	June 30,		December 31,
	2020		2019
Accrued legal and accounting fees	$	378	$	256
Accrued payroll and other benefits		119		231
Interest payable		56		69
Accrued incentive compensation		24		332
Other		28		57
Total	$	605	$	945

Reconciliation of Numerator and Denominator Used in Calculation of Basic and Diluted Net (Loss) per Share Available to Common Stockholders

The following is a reconciliation of the numerator (net loss) and the denominator (number of shares) used in the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except per share amounts):


	Three Months Ended June 30,				Six Months Ended June 30,
	2020		2019		2020		2019
Numerator
Net loss available to common stockholders	$	(3,533)	$	(4,072)	$	(8,291)	$	(839)

Denominator
Weighted average shares used in computing basic and diluted net loss per share available to common stockholders		10,824		8,725		10,292		8,716
Basic and diluted net loss per share of common stock	$	(0.33)	$	(0.47)	$	(0.81)	$	(0.10)

Outstanding Securities Considered Anti-Dilutive

The following table shows the weighted-average outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net loss per share attributable to common stockholders (in thousands):


	Three Months Ended June 30,		Six Months Ended June 30,
	2020	2019	2020	2019
Convertible preferred stock	5,196	6,256	5,726	6,256
Common stock options	564	1,934	578	1,861
Warrants for common stock	19	28	19	27
Total	5,779	8,218	6,323	8,144